Chrisitne Ann Fox's Insider Trades & SAST Disclosures
Chrisitne Ann Fox's most recent trade in Mereo Biopharma Group Plc - ADR was a trade of 262,000 Share Options (Right to buy) done . Disclosure was reported to the exchange on Jan. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Chrisitne Ann Fox.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2025 | 262,000 | 262,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.22 per share. | 12 Sep 2024 | 19,158 | 89,285 | - | 4.2 | 80,866 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.47 per share. | 12 Sep 2024 | 9,128 | 108,443 | - | 4.5 | 40,827 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 60,000 | 0 | - | - | Performance Based Restricted Stock Unit | |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 60,000 | 117,571 | - | 0 | American Depositary Shares representing Ordinary Shares | |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.39 per share. | 25 Jun 2024 | 29,439 | 57,571 | - | 3.4 | 99,892 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.69 per share. | 25 Jun 2024 | 12,990 | 87,010 | - | 3.7 | 47,984 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 90,000 | 60,000 | - | - | Performance Based Restricted Stock Unit | |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 90,000 | 100,000 | - | 0 | American Depositary Shares representing Ordinary Shares | |
| Mereo Biopharma Group Plc ... | Chrisitne Ann Fox | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 245,000 | 245,000 | - | - | Share Options (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges